In a study published Dec. 14 in The International Journal of Oral & Maxillofacial Implants, a research team led by a team at the University of Zurich found that low-dose CBCT imaging protocols provide accurate 3D anatomical information with an improved benefit-risk ratio. Researchers said the use of low-dose CBCT could become “a promising option as a primary diagnostic modality as well as for radiologic follow-up,” according to the study.
In this preclinical comparison study, researchers assessed the diagnostic accuracy of low-dose CBCT protocols compared with standard-dose in digital implant treatment planning and template-guided implant surgery. The team analyzed 30 mandibles of pig cadavers using both CBCT protocols on an Orthophos SL Unit (Dentsply-Sirona).
They conducted surface scans to create a digital diagnostic wax-up followed by 120 subsequent implant plannings (one implant per quadrant). Using simple randomization (1:1), researchers assigned each quadrant into one of the imaging protocols.
Sixty implant surgical guides were manufactured using CAD/CAM technology, followed by the fully guided placement of 60 implants following the surgical protocol in randomized order. Geometric accuracy between the planned and definitive implant position was determined regarding apical distances between the central axes and angle deviation. Descriptive statistics and linear regressions were used for the statistical analysis of the data.
The team observed the following differences: apical deviation of 0.75 ± 0.63 mm and angular deviation of 2.5 ± 2.12 degrees, while the standard-dose CBCT showed the following results: apical deviation of 0.92 ± 0.55 mm and angular deviation of 3.06 ± 2.12 degrees.
The regression analyses could not show evidence for a significant difference between the two CBCT protocols, neither regarding the apical distance nor in view of the angular deviation.
Read more in the journal at: http://www.quintpub.com/journals/omi/abstract.php?article_id=22884#.Y6tk1tXMJPY
News 08 May 2026
Maria Gutierrez in Yorba Linda, California, has added the DEXIS Orthopantomograph OP 3D EX cone beam computed tomography (CBCT) system to its practice.
Products 23 February 2026
Next Generation Trident X-View 3D CBCT Product Line Now Available Through Mid America Dental Sales
The next generation Trident X-View 3D CBCT product line is now available through Mid America Dental Sales, a master distributor of dental technology. These advanced imaging systems from Italy are...
Products 22 December 2025
AI dental company announces 510(k) clearance from the U.S. Food and Drug Administration for Overjet CBCT Assist.
Products 24 September 2025
With top-of-the-line 3D imaging technology and all the essential dental imaging programs, Planmeca’s latest offering easily meets the everyday needs of general dentistry, endodontics, and...
Periodontology 10 September 2025
To update the findings of a systematic review from the year 2016 on the evidence for the accuracy and potential benefits of cone beam computed tomography (CBCT) in periodontal diagnostics.
USA 12 July 2026 - 30 November -0001
DSO Leadership Summit 2026 in Austin: Event Preview and Professional Highlights
The DSO Leadership Summit 2026 will take place from September 10, 2026 to September 12, 2026 in Austin, TX, USA, offering dental professionals a focused environment for continuing education, clinical...
Aligners F22® is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 10 July 2026
Planmeca introduces two dental units designed to support modern clinical workflows through different concepts and use cases.
News 10 July 2026
BIOLASE, a MegaGen company and global leader in dental laser technology, today announced a significant investment in its Corona, California, manufacturing operations, underscoring
News 10 July 2026
Led by Farhad Boltchi, DMD, and Darin Dichter, DMD, the program provides a real-time look at the clinical decisions that shape anterior implant outcomes